News and Announcements

How RNA Editing May Promote Tumor Growth

March 21st, 2016in Publications

Thursday, March 17 2016 | Source: BUSM A new study provides insight on the potential role played by RNA (ribonucleic acid) editing in cancer. The findings, which appear online in the journal Scientific Reports, may further our understanding of an emerging mechanism implicated in tumor initiation and progression, and may thus lead to... More

Avrum Spira Leads “Stand Up to Cancer” Dream Team

November 2nd, 2017in Featured, Funding, Research Highlight

Wednesday, November 1, 2017 Written by: Sara Rimer | Source: BUToday Armed with $12 million, researchers aim for early detection of lung cancer Can lung cancer, rarely diagnosed until it’s in an advanced and deadly stage, be nipped in the bud? Avrum Spira and his team intend to find out. Spira (ENG’02), Alexander Graham Bell Professor in Health... More

Boston researchers to head $16.6 million effort to ‘intercept’ cancer

Thursday, October 26, 2017 Written by: Sophia Eppolito | Source: Boston Globe The nonprofit Stand Up To Cancer is launching a $16.6 million program to investigate new ways of halting lung and pancreatic cancers in the early stages, and Boston scientists will head up three of the four research teams. The group, which is announcing the program... More

William Johnson Receives U01 Grant

October 25th, 2017in Funding, Research Highlight

Wednesday, October 25, 2017 Source: BUSM Office of the Dean Recognition for Large Q1 Grants BUSM has received more than $39 million in grant funding during the first quarter of FY18. New awards and renewals with more than $1 million in total anticipated costs over the life of the award include: (*=award not yet... More

Vijaya Kolachalama Receives AHA Grant to Improve Cardiovascular Treatments

Wednesday, August 16, 2017 Source: BUResearch Vijaya B. Kolachalama, PhD, assistant professor of medicine at BUSM, has received a Scientist Development grant from the American Heart Association (AHA). The $231,000 award will fund his three-year study, “Mechanisms of drug-coated balloon therapy.” This project will focus on developing models for smarter artery care including... More

BU Paves Way for MED Prof’s $10M Plus Partnership with Industry

April 7th, 2017in Research Highlight

Monday, April 3, 2017 Written by: Sara Rimer | Source: BUToday As a pulmonary physician scientist, Avi Spira is driven to get his breakthroughs in molecular biomarkers for the early diagnosis of lung cancer and chronic obstructive pulmonary disease (COPD) into clinical care. “I’m a doctor, I want to help people,” says Spira (ENG’02), More

Finding Lung Cancer in the Nose

March 7th, 2017in Research Highlight

Tuesday, February 28, 2017 Written by: Barbara Moran | Source: BUToday Lung cancer is the deadliest form of cancer in the United States—and in the world. According to the National Cancer Institute, it accounts for more than a quarter of cancer deaths in this country, killing about 158,000 people in 2016. Because lung cancer... More

Six Junior Faculty Receive Career Development Awards

September 27th, 2016in Research Highlight

Written by: Amy Laskowski | Source: Bostonia Jerry Chen received quite a present just three months after arriving at BU. Chen, a College of Arts & Sciences assistant professor of biology, is the winner of this year’s Stuart and Elizabeth Pratt Career Development Professorship, which highlights excellence within CAS. A neuroscientist who uses... More

New Consortium to Study Environmental Causes of Breast Cancer

August 17th, 2016in Research Highlight

Written by: Rich Barlow | Source: BU Research Cancer researcher David Sherr is gunning for a disease that has upended his life. His wife died from multiple myeloma 15 years ago. So when the Art beCAUSE Breast Cancer Foundation, a nonprofit supporting research into the environmental causes of breast cancer, approached him for ideas to... More

Stopping Lung Cancer Before It Gets Going

March 22nd, 2016in Funding, Research Highlight

March 7, 2016 | Written By: Upal Basu Roy, MPH, PhD | Source: LUNGevity “The LUNGevity award provided me the resources to study premalignant lung cells—a stage in which normal lung cells have changed, but not yet completely into cancer cells. This is an extremely important area of cancer research for... More